Q2 2025 Cellebrite DI Ltd Earnings Call Transcript
Key Points
- Cellebrite DI Ltd (CLBT) reported a 21% growth in Annual Recurring Revenue (ARR) to $419 million, driven by increased spending within its customer base.
- The company saw strong adoption of its cloud and SaaS-based solutions, which now account for 20% of total ARR, with Guardian's ARR growing by more than 100% year-on-year for the fourth consecutive quarter.
- Cellebrite DI Ltd (CLBT) announced its acquisition of Corellium, which is expected to accelerate innovation and expand its addressable market, particularly in the defense and intelligence sector.
- The company achieved a gross margin of 85% and a 29% increase in adjusted EBITDA to $27.9 million, reflecting strong operating leverage.
- Cellebrite DI Ltd (CLBT) ended the quarter with $558 million in cash, cash equivalents, and investments, indicating strong financial health and liquidity.
- Cellebrite DI Ltd (CLBT) faces uncertainty in US federal spending, impacting its financial targets for 2025 due to atypical spending activity and constrained visibility into the timing of new orders.
- The company experienced a modest quarter in the private sector, which contributed to a cautious outlook for the remainder of the year.
- Despite strong demand signals, the timing of orders from the US Federal segment remains uncertain, affecting the company's ARR and revenue expectations.
- Cellebrite DI Ltd (CLBT) has adjusted its full-year ARR and revenue expectations due to minimal growth from US federal customers, impacting total ARR growth by approximately 4 percentage points.
- The company has scaled back planned hiring in 2025 to maintain its financial performance amid federal spending headwinds, which could impact future growth initiatives.
(Operator Instructions)
Welcome to the Cellebrite second-quarter 2025 financial results conference call. (Operator Instructions)
I would now like to turn call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.
Thank you very much, Angela. Good morning, everybody. Welcome to Cellebriteâs second quarter 2025 financial results conference call. I'm joined here today at our US headquarters outside of Washington, D.C. Our primary speakers on the call will be Tom Hogan, Cellebrite CEO; and David Barter, Cellebrite CFO.
Also with us in the room are Dana Gerner, our former CFO; and Marcus Jewell, our CRO. Joining us remotely will be Adam Clammer, Cellebriteâs Chairman of the Board, who will also have some remarks for today. This call is being recorded, and a replay of the recording will be made available on our website shortly after the call. And eventually, we will post a copy of our prepared remarks.
Please note that a copy of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

